<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33394258</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1364-6753</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Neurogenetics</Title><ISOAbbreviation>Neurogenetics</ISOAbbreviation></Journal><ArticleTitle>SPG43 and ALS-like syndrome in the same family due to compound heterozygous mutations of the C19orf12 gene: a case description and brief review.</ArticleTitle><Pagination><StartPage>95</StartPage><EndPage>101</EndPage><MedlinePgn>95-101</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10048-020-00631-4</ELocationID><Abstract><AbstractText>C19orf12 gene biallelic mutations lead mainly to neurodegeneration with brain iron accumulation-4. A 15-year-old male and his 17-year-old sister complained of cramps and exercise intolerance. Clinical examination of the boy mainly showed distal amyotrophy and mild weakness, while the sister predominantly had a tetrapyramidal syndrome. Widespread chronic neurogenic signs and hypointense signals on the striatum were present in both patients. Clinical exome sequencing identified, on both patients, the compound heterozygous pathogenic mutations c.204_214del p.(Gly69ArgfsTer10) and c.32C&gt;T p.(Thr11Met). The description of these rare SPG43 and ALS-like phenotypes in the same family contributes to improve genotype-phenotype correlation in C19orf12-related diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Remiche</LastName><ForeName>Gauthier</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-4882-3570</Identifier><AffiliationInfo><Affiliation>Centre de R&#xe9;f&#xe9;rence Neuromusculaire, Department of Neurology, Cliniques Universitaires de Bruxelles, H&#xf4;pital Erasme, Universit&#xe9; libre de Bruxelles (ULB), Route de Lennik 808, 1070, Brussels, Belgium. gauthier.remiche@erasme.ulb.ac.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandernoot</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Genetics, Cliniques Universitaires de Bruxelles, H&#xf4;pital Erasme, Universit&#xe9; libre de Bruxelles (ULB), Route de Lennik 808, 1070, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadeghi-Meibodi</LastName><ForeName>Niloufar</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Radiology, Cliniques Universitaires de Bruxelles, H&#xf4;pital Erasme, Universit&#xe9; libre de Bruxelles (ULB), Route de Lennik 808, 1070, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desmyter</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Genetics, Cliniques Universitaires de Bruxelles, H&#xf4;pital Erasme, Universit&#xe9; libre de Bruxelles (ULB), Route de Lennik 808, 1070, Brussels, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurogenetics</MedlineTA><NlmUniqueID>9709714</NlmUniqueID><ISSNLinking>1364-6745</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568481">C19orf12 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024101">Mitochondrial Proteins</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C565957">Amyotrophic Lateral Sclerosis 2, Juvenile</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="Y">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024101" MajorTopicYN="N">Mitochondrial Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">C19orf12</Keyword><Keyword MajorTopicYN="N">NBIA4</Keyword><Keyword MajorTopicYN="N">SPG43</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>4</Day><Hour>12</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33394258</ArticleId><ArticleId IdType="doi">10.1007/s10048-020-00631-4</ArticleId><ArticleId IdType="pii">10.1007/s10048-020-00631-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Meilleur KG, Traore M, Sangare M, Britton A, Landoure G, Coulibaly S, Niare B, Mochel F, La Pean A, Rafferty I, Watts C, Shriner D, Littleton-Kearney MT, Blackstone C, Singleton A, Fischbeck KH (2010) Hereditary spastic paraplegia and amyotrophy associated with a novel locus on chromosome 19. Neurogenetics 11(3):313&#x2013;318. https://doi.org/10.1007/s10048-009-0230-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-009-0230-0</ArticleId><ArticleId IdType="pubmed">20039086</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoure G, Zhu PP, Lourenco CM, Johnson JO, Toro C, Bricceno KV, Rinaldi C, Meilleur KG, Sangare M, Diallo O, Pierson TM, Ishiura H, Tsuji S, Hein N, Fink JK, Stoll M, Nicholson G, Gonzalez MA, Speziani F, Durr A, Stevanin G, Biesecker LG, Center NIHIS, Accardi J, Landis DM, Gahl WA, Traynor BJ, Marques W Jr, Zuchner S, Blackstone C, Fischbeck KH, Burnett BG (2013) Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12. Hum Mutat 34(10):1357&#x2013;1360. https://doi.org/10.1002/humu.22378</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22378</ArticleId><ArticleId IdType="pubmed">23857908</ArticleId></ArticleIdList></Reference><Reference><Citation>Deschauer M, Gaul C, Behrmann C, Prokisch H, Zierz S, Haack TB (2012) C19orf12 mutations in neurodegeneration with brain iron accumulation mimicking juvenile amyotrophic lateral sclerosis. J Neurol 259(11):2434&#x2013;2439. https://doi.org/10.1007/s00415-012-6521-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-012-6521-7</ArticleId><ArticleId IdType="pubmed">22584950</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartig MB, Iuso A, Haack T, Kmiec T, Jurkiewicz E, Heim K, Roeber S, Tarabin V, Dusi S, Krajewska-Walasek M, Jozwiak S, Hempel M, Winkelmann J, Elstner M, Oexle K, Klopstock T, Mueller-Felber W, Gasser T, Trenkwalder C, Tiranti V, Kretzschmar H, Schmitz G, Strom TM, Meitinger T, Prokisch H (2011) Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. Am J Hum Genet 89(4):543&#x2013;550. https://doi.org/10.1016/j.ajhg.2011.09.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2011.09.007</ArticleId><ArticleId IdType="pubmed">21981780</ArticleId><ArticleId IdType="pmc">3188837</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogarth P, Gregory A, Kruer MC, Sanford L, Wagoner W, Natowicz MR, Egel RT, Subramony SH, Goldman JG, Berry-Kravis E, Foulds NC, Hammans SR, Desguerre I, Rodriguez D, Wilson C, Diedrich A, Green S, Tran H, Reese L, Woltjer RL, Hayflick SJ (2013) New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN. Neurology 80(3):268&#x2013;275. https://doi.org/10.1212/WNL.0b013e31827e07be</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31827e07be</ArticleId><ArticleId IdType="pubmed">23269600</ArticleId><ArticleId IdType="pmc">3589182</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi M, Annesi G, Lesca G, Broussolle E, Iannello G, Vaiti V, Gambardella A, Quattrone A (2015) C19orf12 gene mutations in patients with neurodegeneration with brain iron accumulation. Parkinsonism Relat Disord 21(7):813&#x2013;816. https://doi.org/10.1016/j.parkreldis.2015.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2015.04.009</ArticleId><ArticleId IdType="pubmed">25962551</ArticleId></ArticleIdList></Reference><Reference><Citation>Olgiati S, Dogu O, Tufekcioglu Z, Diler Y, Saka E, Gultekin M, Kaleagasi H, Kuipers D, Graafland J, Breedveld GJ, Quadri M, Surmeli R, Sunter G, Dogan T, Yalcin AD, Bilgic B, Elibol B, Emre M, Hanagasi HA, Bonifati V (2017) The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN. Parkinsonism Relat Disord 39:64&#x2013;70. https://doi.org/10.1016/j.parkreldis.2017.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2017.03.012</ArticleId><ArticleId IdType="pubmed">28347615</ArticleId></ArticleIdList></Reference><Reference><Citation>Schottmann G, Stenzel W, Lutzkendorf S, Schuelke M, Knierim E (2014) A novel frameshift mutation of C19ORF12 causes NBIA4 with cerebellar atrophy and manifests with severe peripheral motor axonal neuropathy. Clin Genet 85(3):290&#x2013;292. https://doi.org/10.1111/cge.12137</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cge.12137</ArticleId><ArticleId IdType="pubmed">23521069</ArticleId></ArticleIdList></Reference><Reference><Citation>Sparber P, Marakhonov A, Filatova A, Sharkova I, Skoblov M (2018) Novel case of neurodegeneration with brain iron accumulation 4 (NBIA4) caused by a pathogenic variant affecting splicing. Neurogenetics 19(4):257&#x2013;260. https://doi.org/10.1007/s10048-018-0558-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-018-0558-4</ArticleId><ArticleId IdType="pubmed">30392167</ArticleId></ArticleIdList></Reference><Reference><Citation>Monfrini E, Melzi V, Buongarzone G, Franco G, Ronchi D, Dilena R, Scola E, Vizziello P, Bordoni A, Bresolin N, Comi GP, Corti S, Di Fonzo A (2018) A de novo C19orf12 heterozygous mutation in a patient with MPAN. Parkinsonism Relat Disord 48:109&#x2013;111. https://doi.org/10.1016/j.parkreldis.2017.12.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2017.12.025</ArticleId><ArticleId IdType="pubmed">29295770</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruer MC, Salih MA, Mooney C, Alzahrani J, Elmalik SA, Kabiraj MM, Khan AO, Paudel R, Houlden H, Azzedine H, Alkuraya F (2014) C19orf12 mutation leads to a pallido-pyramidal syndrome. Gene 537(2):352&#x2013;356. https://doi.org/10.1016/j.gene.2013.11.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2013.11.039</ArticleId><ArticleId IdType="pubmed">24361204</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogu O, Krebs CE, Kaleagasi H, Demirtas Z, Oksuz N, Walker RH, Paisan-Ruiz C (2013) Rapid disease progression in adult-onset mitochondrial membrane protein-associated neurodegeneration. Clin Genet 84(4):350&#x2013;355. https://doi.org/10.1111/cge.12079</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cge.12079</ArticleId><ArticleId IdType="pubmed">23278385</ArticleId></ArticleIdList></Reference><Reference><Citation>Gore E, Appleby BS, Cohen ML, DeBrosse SD, Leverenz JB, Miller BL, Siedlak SL, Zhu X, Lerner AJ (2016) Clinical and imaging characteristics of late onset mitochondrial membrane protein-associated neurodegeneration (MPAN). Neurocase 22(5):476&#x2013;483. https://doi.org/10.1080/13554794.2016.1247458</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13554794.2016.1247458</ArticleId><ArticleId IdType="pubmed">27801611</ArticleId><ArticleId IdType="pmc">5568540</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte EC, Claussen MC, Jochim A, Haack T, Hartig M, Hempel M, Prokisch H, Haun-Junger U, Winkelmann J, Hemmer B, Forschler A, Ilg R (2013) Mitochondrial membrane protein associated neurodegeneration: a novel variant of neurodegeneration with brain iron accumulation. Mov Disord 28(2):224&#x2013;227. https://doi.org/10.1002/mds.25256</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.25256</ArticleId><ArticleId IdType="pubmed">23436634</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschentscher A, Dekomien G, Ross S, Cremer K, Kukuk GM, Epplen JT, Hoffjan S (2015) Analysis of the C19orf12 and WDR45 genes in patients with neurodegeneration with brain iron accumulation. J Neurol Sci 349(1&#x2013;2):105&#x2013;109. https://doi.org/10.1016/j.jns.2014.12.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.12.036</ArticleId><ArticleId IdType="pubmed">25592411</ArticleId></ArticleIdList></Reference><Reference><Citation>Dezfouli MA, Alavi A, Rohani M, Rezvani M, Nekuie T, Klotzle B, Tonekaboni SH, Shahidi GA, Elahi E (2013) PANK2 and C19orf12 mutations are common causes of neurodegeneration with brain iron accumulation. Mov Disord 28(2):228&#x2013;232. https://doi.org/10.1002/mds.25271</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.25271</ArticleId><ArticleId IdType="pubmed">23166001</ArticleId></ArticleIdList></Reference><Reference><Citation>Klysz B, Skowronska M, Kmiec T (2014) Mitochondrial protein associated neurodegeneration - case report. Neurol Neurochir Pol 48(1):81&#x2013;84. https://doi.org/10.1016/j.pjnns.2013.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pjnns.2013.09.002</ArticleId><ArticleId IdType="pubmed">24636776</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman JG, Eichenseer SR, Berry-Kravis E, Zimnowodzki S, Gregory A, Hogarth P, Hayflick SJ (2013) Clinical features of neurodegeneration with brain iron accumulation due to a C19orf12 gene mutation. Mov Disord 28(10):1462&#x2013;1463. https://doi.org/10.1002/mds.25410</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.25410</ArticleId><ArticleId IdType="pubmed">23494994</ArticleId></ArticleIdList></Reference><Reference><Citation>Selikhova M, Fedotova E, Wiethoff S, Schottlaender LV, Klyushnikov S, Illarioshkin SN, Houlden H (2017) A 30-year history of MPAN case from Russia. Clin Neurol Neurosurg 159:111&#x2013;113. https://doi.org/10.1016/j.clineuro.2017.05.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2017.05.025</ArticleId><ArticleId IdType="pubmed">28641177</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasapkara CS, Tumer L, Gregory A, Ezgu F, Inci A, Derinkuyu BE, Fox R, Rogers C, Hayflick S (2019) A new NBIA patient from Turkey with homozygous C19ORF12 mutation. Acta Neurol Belg 119(4):623&#x2013;625. https://doi.org/10.1007/s13760-018-1026-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-018-1026-5</ArticleId><ArticleId IdType="pubmed">30298423</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory A, Lotia M, Jeong SY, Fox R, Zhen D, Sanford L, Hamada J, Jahic A, Beetz C, Freed A, Kurian MA, Cullup T, van der Weijden MCM, Nguyen V, Setthavongsack N, Garcia D, Krajbich V, Pham T, Woltjer R, George BP, Minks KQ, Paciorkowski AR, Hogarth P, Jankovic J, Hayflick SJ (2019) Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN). Mol Genet Genomic Med 7(7):e00736. https://doi.org/10.1002/mgg3.736</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mgg3.736</ArticleId><ArticleId IdType="pubmed">31087512</ArticleId><ArticleId IdType="pmc">6625130</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Committee ALQA (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405&#x2013;424. https://doi.org/10.1038/gim.2015.30</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId><ArticleId IdType="pubmed">25741868</ArticleId><ArticleId IdType="pmc">25741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Association AP (2013) Attention-deficit/hyperactivity disorder. In: Association AP (ed) Diagnostic and statistical manual of mental disorders, Fifth Edition. Arlington, VA, p 59</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.books.9780890425596</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Meo I, Tiranti V (2018) Classification and molecular pathogenesis of NBIA syndromes. Eur J Paediatr Neurol 22(2):272&#x2013;284. https://doi.org/10.1016/j.ejpn.2018.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpn.2018.01.008</ArticleId><ArticleId IdType="pubmed">29409688</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.phosphosite.org//proteinAction?id=4855191&amp;showAllSites=true</Citation></Reference><Reference><Citation>Wang ZB, Liu JY, Xu XJ, Mao XY, Zhang W, Zhou HH, Liu ZQ (2019) Neurodegeneration with brain iron accumulation: insights into the mitochondria dysregulation. Biomed Pharmacother 118:109068. https://doi.org/10.1016/j.biopha.2019.109068</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2019.109068</ArticleId><ArticleId IdType="pubmed">31404774</ArticleId></ArticleIdList></Reference><Reference><Citation>Arber CE, Li A, Houlden H, Wray S (2016) Review: insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories. Neuropathol Appl Neurobiol 42(3):220&#x2013;241. https://doi.org/10.1111/nan.12242</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12242</ArticleId><ArticleId IdType="pubmed">25870938</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiese M, Bannister AJ (2020) Two genomes, one cell: mitochondrial-nuclear coordination via epigenetic pathways. Mol Metab:100942. https://doi.org/10.1016/j.molmet.2020.01.006</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>